Date published: 2026-6-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

V1RD22 Activators

Chemical activators of V1RD22 can initiate a cascade of intracellular events leading to the functional activation of this protein. Forskolin, known for its ability to directly stimulate adenylyl cyclase, results in an elevation of cAMP levels within the cell, which in turn activates protein kinase A (PKA). Once activated, PKA can phosphorylate target proteins such as V1RD22, leading to their activation. Isoproterenol, a beta-adrenergic agonist, similarly raises intracellular cAMP levels, further engaging PKA and promoting the phosphorylation and activation of V1RD22. Another agent, Vardenafil, functions differently by inhibiting phosphodiesterase type 5, which prevents the breakdown of cGMP, thereby increasing its concentration. Elevated cGMP levels activate protein kinase G (PKG), which then can phosphorylate and activate V1RD22. Similarly, IBMX also prevents the breakdown of cAMP by inhibiting phosphodiesterases, thus sustaining PKA activity, which is crucial for the phosphorylation and consequent activation of V1RD22.

Prostaglandin E2 and Histamine, through their interactions with their respective receptors, both culminate in raised cAMP levels, ultimately activating PKA, which is implicated in the activation of V1RD22 via phosphorylation. On another pathway, Sodium Nitroprusside acts by releasing nitric oxide, which stimulates guanylyl cyclase to produce cGMP, activating PKG, leading to the phosphorylation and subsequent activation of V1RD22. Angiotensin II, through the AT1 receptor, activates phospholipase C (PLC), which results in the activation of protein kinase C (PKC), another kinase that can phosphorylate and activate V1RD22. Diacylglycerol, a direct activator of PKC, similarly promotes the phosphorylation and activation of V1RD22. Anisomycin, which activates the JNK signaling pathway, includes kinases that directly phosphorylate and activate V1RD22. Epinephrine and Glucagon, both through their respective receptors, increase cAMP production, setting the stage for PKA-mediated phosphorylation and activation of V1RD22. Each of these chemicals, through their distinct pathways, converge on the activation of V1RD22 by fostering an environment that promotes its phosphorylation and subsequent activation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol, a beta-adrenergic agonist, increases cAMP concentrations, thus activating PKA which could phosphorylate and activate V1RD22.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$526.00
$735.00
$16653.00
7
(1)

Vardenafil inhibits phosphodiesterase type 5, leading to increased cGMP levels which can activate PKG that may phosphorylate and activate V1RD22.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX inhibits phosphodiesterases, increasing cAMP levels, and thereby sustaining PKA activity which could phosphorylate and activate V1RD22.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$94.00
$283.00
$988.00
7
(1)

Histamine, through its action on H2 receptors, raises cAMP levels, possibly activating PKA to phosphorylate and activate V1RD22.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

Prostaglandin E2 interacts with EP receptors to increase cAMP, which can activate PKA and lead to phosphorylation and activation of V1RD22.

Sodium nitroprusside dihydrate

13755-38-9sc-203395
sc-203395A
sc-203395B
1 g
5 g
100 g
$43.00
$85.00
$158.00
7
(1)

Sodium Nitroprusside releases nitric oxide, which stimulates guanylyl cyclase to produce cGMP, activating PKG to phosphorylate and activate V1RD22.

Angiotensin II, Human

4474-91-3sc-363643
sc-363643A
sc-363643B
sc-363643C
1 mg
5 mg
25 mg
100 mg
$51.00
$100.00
$310.00
$690.00
3
(1)

Angiotensin II engages the AT1 receptor, initiating PLC pathway and activation of PKC, which can phosphorylate and activate V1RD22.

1,2-Dioctanoyl-sn-glycerol

60514-48-9sc-202397
sc-202397A
10 mg
50 mg
$47.00
$254.00
2
(1)

Diacylglycerol activates PKC that could lead to the phosphorylation and subsequent activation of V1RD22.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin activates the JNK signaling pathway, which includes kinases that can directly phosphorylate and activate V1RD22.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Epinephrine, via beta-adrenergic receptors, elevates cAMP levels, which can lead to activation of V1RD22 through PKA phosphorylation.